Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsPfizer update: final analysis confirms 95% efficacy, ready to seek emergency approval "within days"
https://www.cnn.com/2020/11/18/health/pfizer-coronavirus-vaccine-safety/index.html"Final analysis of the Phase 3 trial of Pfizer's coronavirus vaccine shows it was 95% effective in preventing infections, even in older adults, and caused no serious safety concerns, the company said Wednesday.
The company counted 170 cases of coronavirus infection among volunteers who took part in the trial. It said 162 infections were in people who got placebo, or plain saline shots, while eight cases were in participants who got the actual vaccine. That works out to an efficacy of 95%, Pfizer said.
The data show Pfizer's initial claim of a better than 90% efficacy -- a claim that stunned and pleased health officials and vaccine developers last week -- holds up.
"Efficacy was consistent across age, race and ethnicity demographics. The observed efficacy in adults over 65 years of age was over 94%," Pfizer and its German partner BioNTech said in a joint statement.
Pfizer has enough safety data about its coronavirus vaccine and is preparing to submit for FDA authorization, CEO says..." (more )
InfoView thread info, including edit history
TrashPut this thread in your Trash Can (My DU » Trash Can)
BookmarkAdd this thread to your Bookmarks (My DU » Bookmarks)
4 replies, 474 views
ShareGet links to this post and/or share on social media
AlertAlert this post for a rule violation
PowersThere are no powers you can use on this post
EditCannot edit other people's posts
ReplyReply to this post
EditCannot edit other people's posts
Rec (5)
ReplyReply to this post
4 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
Pfizer update: final analysis confirms 95% efficacy, ready to seek emergency approval "within days" (Original Post)
Tanuki
Nov 2020
OP
global1
(25,168 posts)1. Are These Vaccine Companies Playing A Game Of....
one upsmanship?
Tanuki
(14,893 posts)2. Pfizer initially reported efficacy of "more than 90%." They now have a larger
number of subjects for analysis and can be more exact in the percentage. I think both Pfizer and Moderna will have plenty of "customers" and more demand for their respective vaccines than either could handle for the foreseeable future. It was really good news that Pfizer's vaccine seems equally effective across demographics including age (i.e., over age 65). Maybe the same is true for the Moderna vax, but I didn't see it reported. I think all of this is wonderful news and I would gladly accept innoculation with either vaccine as soon as it is available (barring any breaking bad news, of course).
blueinredohio
(6,797 posts)3. Were the participants of this trial all healthy?
Did it include some with co morbities?
mnhtnbb
(31,319 posts)4. The press release from Pfizer and link to the diversity of clinical trial participants
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine
Approximately 150 clinical trial sites covering 6 countries and 39 US States and breakdown of participant diversity
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine
Approximately 150 clinical trial sites covering 6 countries and 39 US States and breakdown of participant diversity
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine